| 1. | Elderly people particularly are subjected to polypharmacy ( taking multiple medications ).
|
| 2. | Polypharmacy is associated with an increased risk of falls in the elderly.
|
| 3. | This polypharmacy may increase the risk of drug interactions or adverse drug reactions.
|
| 4. | A downward dose adjustment may be necessary with this particular instance of polypharmacy.
|
| 5. | Complex health issues, polypharmacy, and recently approved medications are also addressed.
|
| 6. | There are many ways patients and their doctors can avoid the hazards of polypharmacy.
|
| 7. | Polypharmacy is often a predictive factor ( Cannon et al ., 2006 ).
|
| 8. | A potential role pharmacogenomics may play would be to reduce the occurrence of polypharmacy.
|
| 9. | Polypharmacy has also shown to have increased since 2000 from 23 % to 29 %.
|
| 10. | Polypharmacy is often associated with a decreased quality of life, decreased mobility and cognition.
|